Strs Ohio Sells 1,800 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Strs Ohio reduced its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 4.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 38,200 shares of the biopharmaceutical company’s stock after selling 1,800 shares during the quarter. Strs Ohio’s holdings in Halozyme Therapeutics were worth […]
More Stories
Hawaii’s Big Island Prepares as Lala Strengthens to Hurricane Ahead of Possible Landfall
By Jeremy Lott Tropical Storm Lala has strengthened to a hurricane and could be the first to make landfall over...
US Tells EU ‘Now It’s Time to Deliver’ on Trade Commitments
By Bill Pan The United States is urging the European Union to further ease its corporate environmental rules, citing commitments...
Iran Accuses Qatar of Holding 3 of Its Military Pilots Captive
By Ryan Morgan The Iranian military, on Aug. 15, claimed three of its pilots are currently being held by Qatar,...
US Mortgage Rates Fall for First Time in 6 Weeks
By Naveen Athrappully The weekly average rate on a 30-year fixed-rate mortgage declined for the most recent week, breaking a...
What Battleground Voters Are Saying About Healthcare Affordability
By Lawrence Wilson “Yes, I do have opinions about this,” said Milwaukee resident Addaru Valentine just after voting in Wisconsin’s...
UAE Accuses Iran of Attacking Abu Dhabi National Oil Company Vessel in Strait of Hormuz
By Jacki Thrapp The United Arab Emirates (UAE) accused the Iranian regime of attacking an Abu Dhabi National Oil Company...